Madison Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Madison Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119,780	Closed	-$3.49M	–	327
2021 Q4	$3.49M	Buy	119,780 +899	+0.8%	+$27.3K	0.05%	223
2021 Q3	$3.17M	Buy	118,881 +459	+0.4%	+$12.3K	0.04%	233
2021 Q2	$3.65M	Sell	118,422 -184	-0.2%	-$5.64K	0.05%	233
2021 Q1	$3.1M	Buy	+118,606	New	+$3.32M	0.04%	234

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Madison Asset Management's SUPN Position: Q1 2022 in Review

Madison Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2022, closing a stake of 119,780 shares — an estimated $3.49M sold.

Madison Asset Management first reported a position in SUPN in Q1 2021 and held it in 4 quarters. The position peaked at $3.65M in Q2 2021. 230 funds tracked by Wall St. Rank hold SUPN as of Q1 2022.

Madison Asset Management reported no remaining Supernus Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Madison Asset Management sold 119,780 Supernus Pharmaceuticals shares in Q1 2022, an estimated $3.49M.
Madison Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2021 and held it in 4 quarters.
Madison Asset Management's Supernus Pharmaceuticals position peaked at $3.65M in Q2 2021.
230 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2022.

Based on Madison Asset Management's 13F filing for Q1 2022, filed 12 May 2022.